KALA Insider Trading Activity and SEC Form 4 Filings
KALA insider trading summary
No open-market insider purchases or sales of KALA BIO, Inc. (KALA) have been reported on SEC Form 4 in the past 12 months.
Latest KALA insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Oct 23, 2025 | Mary Reumuth | Chief Financial Officer | Sell | $793 (967 @ $0.82) |
| Oct 23, 2025 | Mark T Iwicki | Insider | Sell | $125K (154,894 @ $0.81) |
| Oct 22, 2025 | Todd Bazemore | Insider | Sell | $40K (47,768 @ $0.83) |
| Oct 22, 2025 | Mary Reumuth | Chief Financial Officer | Sell | $27K (32,230 @ $0.83) |
| Oct 22, 2025 | Romulus K Brazzell | See Remarks | Sell | $39K (46,748 @ $0.83) |
| Oct 22, 2025 | Darius Kharabi | Chief Business Officer | Sell | $17K (20,806 @ $0.83) |
| Oct 1, 2025 | Julian Baker | Insider | Sell | $641K (462,967 @ $1.38) |
| Oct 1, 2025 | Baker Bros. Advisors LP | Insider | Sell | $641K (462,967 @ $1.38) |
| Oct 1, 2025 | Julian Baker | Insider | Sell | $70K (50,640 @ $1.38) |
| Oct 1, 2025 | Baker Bros. Advisors (GP) LLC | Insider | Sell | $641K (462,967 @ $1.38) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.